RxSight Raises FY2026 Sales Guidance from $120.000M-$135.000M to $140.000M-$160.000M vs $129.250M Est

Benzinga Newsdesk www.benzinga.com Positive 93.6%

Neg 0% Neu 0% Pos 93.6%

RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000 million-$160.000 million vs $129.250 million estimate.